balance equationreview2025-09-30
Difference 63344000 exceeds tolerance 1107082.000. Presentation or filing-vintage differences need review.
Revenue
$103.95M
Fiscal year ended 2026-06-30Operating income
Unavailable
Fiscal year ended 2026-06-30Free cash flow
-$799.00K
Fiscal year ended 2026-06-30Vivid Seats Inc. (SEAT) reported revenue of $103.95M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Vivid Seats Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Miscellaneous Amusement & Recreation.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $103.95M | $97.53M | $97.48M | $104.81M | $114.48M | $133.74M | $165.18M | $152.65M | $170.05M | $160.01M |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Net income | Unavailable | Unavailable | $1.18B | -$30.24M | -$335.41M | -$10.55M | -$9.64M | $10.63M | -$437.00K | $12.87M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | Unavailable | shares 10.82M | Unavailable | Unavailable | Unavailable | shares 10.46M | Unavailable | Unavailable | Unavailable | Unavailable |
| Pretax income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Income tax expense | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Diluted EPS | Unavailable | $-1.35 | Unavailable | Unavailable | Unavailable | $-0.94 | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $136.68M | $143.56M | $102.70M | $145.11M | $153.01M | $199.47M | $243.48M | $202.27M | $234.29M | $154.03M |
| Total assets | $688.80M | $691.74M | $636.87M | $1.11B | $1.15B | $1.61B | $1.64B | $1.61B | $1.65B | $1.59B |
| Current assets | $248.73M | $243.27M | $178.47M | $233.91M | $264.93M | $319.79M | $345.17M | $325.92M | $370.82M | $296.86M |
| Total liabilities | $793.88M | $787.13M | $722.00M | $771.58M | $803.11M | $999.20M | $1.02B | Unavailable | Unavailable | Unavailable |
| Current liabilities | $378.59M | $371.10M | $303.28M | $348.22M | $367.08M | $416.28M | $425.78M | $412.69M | $469.61M | $525.17M |
| Total equity incl. NCI | -$105.08M | -$95.39M | -$85.13M | $272.16M | $217.34M | $380.71M | $261.11M | $329.44M | $155.81M | $139.55M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $26.92M | $28.88M | $18.17M | $23.57M | $32.62M | $27.65M | $19.60M | $22.25M | $30.25M | $29.50M |
| Accounts receivable | $45.04M | $36.42M | $30.66M | $38.48M | $49.53M | $56.86M | $48.32M | $65.31M | $68.63M | $69.65M |
| Goodwill | $283.47M | $283.67M | $283.92M | $648.62M | $649.42M | $945.30M | $943.12M | $946.86M | $941.51M | $944.13M |
| Long-term debt | $15.26M | $15.86M | $16.45M | $17.08M | $17.67M | $18.22M | $18.73M | $15.80M | $16.10M | $15.65M |
| Accounts payable | $230.85M | $224.77M | $153.42M | $199.16M | $204.24M | $226.42M | $232.98M | $224.33M | $266.50M | $307.40M |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$799.00K | $46.01M | -$38.20M | $512.00K | -$28.62M | -$25.29M | $47.79M | -$19.22M | -$13.81M | $39.16M |
| Capital expenditures | $0 | $23.00K | $111.00K | $10.00K | $207.00K | $1.84M | $3.46M | $389.00K | $286.00K | $92.00K |
| Investing cash flow | -$3.82M | -$3.10M | -$3.91M | -$4.60M | -$4.09M | -$7.57M | -$8.90M | -$7.29M | -$5.26M | -$5.29M |
| Financing cash flow | -$1.83M | -$1.82M | $96.00K | -$4.02M | -$13.87M | -$11.57M | -$1.80M | -$6.84M | $99.33M | -$4.61M |
| Net change in cash | -$6.58M | $40.85M | -$42.41M | -$8.27M | -$46.71M | -$43.96M | $36.19M | -$31.96M | $79.55M | $28.44M |
| Stock-based compensation | $4.67M | $4.41M | $2.85M | $11.48M | $11.65M | $10.75M | $12.14M | $10.68M | $19.11M | $8.49M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | $0 | $0 | $3.00K | $2.43M | $9.87M | $5.99M | -$16.00K | $2.93M | $16.96M | $3.10M |
| Depreciation & amortization | $12.32M | $12.31M | $11.70M | $13.72M | $12.34M | $11.62M | $12.58M | $10.67M | $10.50M | $10.48M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | -$799.00K | $45.98M | -$38.31M | $502.00K | -$28.83M | -$27.12M | $44.33M | -$19.61M | -$14.09M | $39.07M |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| FCF margin | -0.8% | 47.2% | -39.3% | 0.5% | -25.2% | -20.3% | 26.8% | -12.8% | -8.3% | 24.4% |
| SBC / revenue | 4.5% | 4.5% | 2.9% | 11.0% | 10.2% | 8.0% | 7.4% | 7.0% | 11.2% | 5.3% |
| Current ratio | 0.66x | 0.66x | 0.59x | 0.67x | 0.72x | 0.77x | 0.81x | 0.79x | 0.79x | 0.57x |
| Revenue YoY growth | -9.2% | -27.1% | -41.0% | -31.3% | -32.7% | -16.4% | -1.2% | -1.1% | 22.2% | 17.2% |
| Net margin | Unavailable | Unavailable | 1212.8% | -28.9% | Unavailable | Unavailable | -5.8% | 7.0% | -0.3% | 8.0% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 0.0% | 0.0% | 0.1% | 0.0% | 0.2% | 1.4% | 2.1% | 0.3% | 0.2% | 0.1% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | 0.06x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SEAT in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-04View SEC filing
10-Q · Filed 2026-05-05View SEC filing
10-K · Filed 2026-03-12View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-06View SEC filing
Reconciliation checks needing review
6 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2025-06-30
Difference 128822000 exceeds tolerance 1149268.000. Presentation or filing-vintage differences need review.
balance equationreview2025-03-31
Difference 225627000 exceeds tolerance 1605538.000. Presentation or filing-vintage differences need review.
balance equationreview2024-12-31
Difference 352922000 exceeds tolerance 1636096.000. Presentation or filing-vintage differences need review.
cash flow reconciliationreview2024-09-30
Operating, investing and financing flows differ from the reported change in cash by 1385000, beyond tolerance 1000000.
balance equationreview2023-12-31
Difference 481742000 exceeds tolerance 1550099.000. Presentation or filing-vintage differences need review.